# Bilibili Inc.: Form 20-F for the period ended Dec 31, 2024

- Company: [Bilibili Inc.](/companies/bili.md) (CIK 1723690)
- Form: 20-F
- Filed: 2025-03-25
- Accepted by EDGAR: Mar 25, 2025, 06:07 ET
- Period: 2024-12-31
- Accession: 0001193125-25-061847
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1723690/000119312525061847/d930276d20f.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1723690/000119312525061847/

## Figures reported in this filing

Standardized XBRL line items for the period ended 2024-12-31.

| Line item | Period | Value | XBRL concept |
| --- | --- | ---: | --- |
| Revenue | 12 months, 2024-01-01 to 2024-12-31 | $3.68bn | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Cost of revenue | 12 months, 2024-01-01 to 2024-12-31 | $2.47bn | us-gaap:CostOfRevenue |
| Gross profit | 12 months, 2024-01-01 to 2024-12-31 | $1.20bn | us-gaap:GrossProfit |
| Research and development | 12 months, 2024-01-01 to 2024-12-31 | $504.9m | us-gaap:ResearchAndDevelopmentExpense |
| Operating income | 12 months, 2024-01-01 to 2024-12-31 | −$184.1m | us-gaap:OperatingIncomeLoss |
| Interest expense | 12 months, 2024-01-01 to 2024-12-31 | $12.2m | us-gaap:InterestExpense |
| Income tax | 12 months, 2024-01-01 to 2024-12-31 | −$5.0m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 12 months, 2024-01-01 to 2024-12-31 | −$186.8m | us-gaap:ProfitLoss |
| Diluted EPS | 12 months, 2024-01-01 to 2024-12-31 | −$0.44 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 12 months, 2024-01-01 to 2024-12-31 | −$0.44 | us-gaap:EarningsPerShareBasic |
| Operating cash flow | 12 months, 2024-01-01 to 2024-12-31 | $824.0m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 12 months, 2024-01-01 to 2024-12-31 | $63.8m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Share repurchases | 12 months, 2024-01-01 to 2024-12-31 | $16.1m | us-gaap:PaymentsForRepurchaseOfCommonStock |
| Cash and equivalents | at 2024-12-31 | $1.40bn | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | at 2024-12-31 | $2.71bn | us-gaap:AssetsCurrent |
| Total assets | at 2024-12-31 | $4.48bn | us-gaap:Assets |
| Current liabilities | at 2024-12-31 | $2.02bn | us-gaap:LiabilitiesCurrent |
| Total liabilities | at 2024-12-31 | $2.55bn | us-gaap:Liabilities |
| Long-term debt | at 2024-12-31 | $447.2m | us-gaap:LongTermDebtNoncurrent |
| Shareholders' equity | at 2024-12-31 | $1.93bn | us-gaap:StockholdersEquity |

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1723690/000119312525061847/d930276d20f.htm

Filed Mar 25, 2025.
Source: SEC EDGAR, the filing index for accession 0001193125-25-061847. Last ingested by Listed: Nov 6, 2026, 12:21 ET. No prices; not investment advice.